The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fischer Laurent since 2019.
This trader's CIK number is 1379344.
At the time of last reporting, Fischer Laurent was the CEO, President and Director of Adverum Biotechnologies, Inc.. (stock ticker symbol ADVM).
Also see all insider trading activities at Adverum Biotechnologies, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ADVM | 0 | $0 | 41,239 | $32,248 | 0 | $0 |
| 2022 | ADVM | 25,000 | $27,800 | 41,082 | $43,957 | 0 | $0 |
| 2021 | ADVM | 43,600 | $243,580 | 0 | $0 | 0 | $0 |
| 2020 | ADVM | 7,692 | $99,996 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | MIRM | 6,750 | $69,537 | 0 | $0 | 0 | $0 |
1. Adverum Biotechnologies, Inc. (ADVM)
2. Mirum Pharmaceuticals, Inc. (MIRM)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-03-15 | ADVM | Sale | 41,239 | .78 | 32,248 |
| 2022-09-19 | ADVM | Sale | 41,082 | 1.07 | 43,957 |
| 2022-04-20 | ADVM | Buy | 25,000 | 1.11 | 27,800 |
| 2021-12-09 | ADVM | Buy | 14,323 | 1.85 | 26,497 |
| 2021-12-08 | ADVM | Buy | 10,677 | 1.79 | 19,111 |
| 2021-03-24 | ADVM | Buy | 10,000 | 9.88 | 98,780 |
| 2021-01-15 | ADVM | Buy | 8,600 | 11.53 | 99,192 |
| 2020-08-17 | ADVM | Buy | 7,692 | 13.00 | 99,996 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-09-16 | MIRM | Buy | 452 | 9.47 | 4,280 |
| 2019-09-17 | MIRM | Buy | 1,648 | 9.37 | 15,435 |
| 2019-09-06 | MIRM | Buy | 1,720 | 10.71 | 18,429 |
| 2019-09-09 | MIRM | Buy | 1,970 | 10.92 | 21,512 |
| 2019-09-10 | MIRM | Buy | 960 | 10.29 | 9,881 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fischer Laurent (CEO, President and Director of Adverum Biotechnologies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.